Relafen 750, structurally known as naproxen, represents a noteworthy case study from a pharmacological pharmacy standpoint. The drug exhibits its pain-relieving click here effect primarily by blocking the activity of cyclooxygenase (COX) enzymes, specifically COX-2, thereby suppressing prostaglandin production . The selective inhibition of COX-2, c